ArticleInternational journal of molecular sciences2020

Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib.

Panagiotis Efentakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.